Title – Global Intramuscular Injector Market By Product (Pre-fillable Injection System and Fillable

Needle-free Injectors), By Application (Hospitals, Clinics, Ambulatory Surgery Centers, Others), By

Geographic Scope & Forecast.

Global Intramuscular Injector Market Size and Forecast

The availability of generic versions of autoinjectors, favorable reimbursements and government support,
and technological advancements have positively anticipated in propelling the growth of the global
intramuscular injectors market.

Global Intramuscular Injector Market Definition

An intramuscular injector is an injecting device used to deliver medications deep into the muscles. At
present, intramuscular injectors are utilized in modern medicine to enable quick absorption of
medication within the bloodstream. Usually, these injectors are extensively used to deliver vaccines and
drugs. Also, these are highly preferred to other drug delivery routes for quick treatment, as muscle
tissues have a higher blood supply as compared to the tissues present under the skin and muscles are
capable of holding a high volume of medication. Intramuscular injections are standard practice in
modern medicine. They’re used to deliver drugs and vaccines. Several drugs and most injectable
vaccines are delivered this manner. These injectors find applications in hospitals, clinics, and ambulatory
surgery centers.

Global Intramuscular Injector Market Overview

The global intramuscular injectors market is driven by growth in the prevalence of chronic diseases that
require medications through muscles, a rise in demand for biosimilars and vaccination, and increased
demand for drug delivery due to its advantages is expected to boost the growth of the global market.
Moreover, the availability of generic versions of autoinjectors, favorable reimbursements and
government support, and technological advancements have positively anticipated in propelling the
growth of the global intramuscular injectors market.

There are certain limitations and obstacles faced that will hinder the overall market growth. The factors
such as the high cost of prefilled injectors and stringent approval process forms are inhibiting the growth
of the market. Also, the dearth of a skilled workforce is limiting the market growth. Further, Alternative
drug delivery modes and lack of proper training for using autoinjectors are the potential restraints
hampering the overall growth of the global intramuscular injectors market. Nevertheless, the
advancements in technologies, increase in the number of investors due to high demand for biologics
development, and untapped potential in emerging markets is anticipated to provide lucrative growth
opportunities to the market.

Global Intramuscular Injector Market by Product

 Pre-fillable Injection System

 Fillable Needle-free Injectors
Based on Product, the market is bifurcated into Pre-fillable Injection System and Fillable Needle-free
Injectors. The pre-fillable injection system segment holds the largest market share during the forecast
period. Prefilled provides high patient safety by diminishing the potential for inadvertent needle sticks
and exposure to toxic products that occur while drawing medication from vials. Prefilled injection, with
their pre measures dosage, decrease dosing failures and enhance patient compliance.

Global Intramuscular Injector Market by Application

 Hospitals
 Clinics
 Ambulatory Surgery Centers
 Others

Based on Application, the market is bifurcated into Hospitals, Clinics, Ambulatory Surgery Centers,
Others. The hospital segment holds the largest market share and is estimated to witness the highest
CAGR during the forecast period. The factors that can be attributed to the growing growth in the
prevalence of chronic diseases are fueling the demand for this segment.

Global Intramuscular Injector Market by Geography

On the basis of regional analysis, the Global Intramuscular Injector Market is classified into North
America, Europe, Asia Pacific, and Rest of the world. Asia-Pacific holds the largest market share. The
increasing healthcare expenditure, establishing sales offices, and partnering with local pharmaceutical
companies, strong governmental initiatives, and ongoing projects will boost the market in the APAC
region.